DR. MEHDI M. MOEZI, MD

Plain English
This study looked at two different surgical techniques for fixing a patellar tendon rupture that had not been treated promptly. One patient had surgery using a piece of Achilles tendon, while the other used a piece of their own patellar tendon with bone. Both methods worked well, allowing patients to move their knees soon after surgery and achieving good recovery results within a year. The choice of graft type is important because it can affect healing, especially if there is bone loss. Who this helps: This helps patients with chronic knee injuries and their doctors in deciding treatment options.

Plain English
This paper corrects previous findings about how physical activity changed for people in Iran during the COVID-19 pandemic. It clarifies that many people reduced their exercise, with only 38% staying active regularly, and outlines the impact of lockdowns on their lifestyle. Understanding these changes is important because it can help shape public health strategies for promoting physical activity during future health crises. Who this helps: This benefits public health officials and community health organizations.

Plain English
This research examined the effectiveness of a treatment combining palbociclib with hormone therapy for patients with advanced breast cancer that is hormone receptor-positive and HER2-negative. The study involved 1,250 patients, showing that 34% of those in their first round of treatment had a positive response, with the treatment helping patients live a median of 20.9 months without their disease worsening, while those who had already received treatment before had lower rates of response and a median progression-free survival of 13.5 months. These findings are important because they confirm that this treatment works well in real-world settings, supporting its use for a diverse group of breast cancer patients who might not have been represented in clinical trials. Who this helps: This benefits patients with HR+/HER2- advanced breast cancer and their healthcare providers.

Plain English
This study looked at how effective and safe two treatments for chronic immune thrombocytopenia (ITP) in adults—fostamatinib and thrombopoietin agents—are in real-life settings. Researchers analyzed data from 179 patients and found that both treatments worked equally well in keeping platelet counts at safe levels, with fostamatinib patients experiencing fewer blood clot events (3.9%) than those on thrombopoietin agents (up to 11.4% for one). The average cost for patients on fostamatinib was about $99,209, which was lower than some of the thrombopoietin agents, suggesting that fostamatinib may be a cost-effective option for ITP treatment. Who this helps: This helps patients with chronic immune thrombocytopenia and their doctors in choosing safer, more economical treatment options.

Plain English
This study looked at how well adding a medication called lenalidomide (LEN) could work for patients with multiple myeloma who were not responding to another treatment using ruxolitinib (RUX) and methylprednisolone (MP). Out of 29 patients, the initial two-drug treatment had a response rate of 31%, but when LEN was added, the response rate was similar at 30%, yet the clinical benefit rate improved to 40%. This finding is important because it shows that LEN can still provide benefits even after multiple prior treatments, giving hope to patients who are running out of options. Who this helps: This helps patients with advanced multiple myeloma who may struggle with treatment options.

Plain English
This study examined the effectiveness of a combination of two medications, ruxolitinib and methylprednisolone, in treating patients with relapsed or refractory multiple myeloma, a type of blood cancer. Out of 29 patients, 31% responded positively to the treatment, with the response lasting an average of 13.1 months. This is important because it shows that this drug combination can benefit patients who have already tried multiple treatments, including those with high-risk genetic features. Who this helps: This helps patients with relapsed multiple myeloma who have limited treatment options.

Plain English
This study looked at three different medications used to prevent nausea and vomiting in cancer patients undergoing chemotherapy. Researchers found that patients using CINVANTI had a lower need for additional medication to control nausea compared to those on Emend, with a likelihood of needing rescue therapy more than 2.5 times higher for the Emend group. This is important because effective control of nausea can improve patients' quality of life during treatment. Who this helps: This helps cancer patients undergoing chemotherapy manage their nausea and vomiting better.

Plain English
This study examined the effectiveness and safety of using ofatumumab together with bendamustine, followed by continued treatment with ofatumumab, in patients with a type of cancer called relapsed indolent non-Hodgkin lymphoma (iNHL) who had previously responded to a treatment called rituximab. Out of 49 patients, 24.5% had a complete response to the treatment, 42.9% had a partial response, and overall, 67.3% showed some level of positive response after the initial treatment. However, many patients experienced side effects, with the most common being a drop in certain blood cells and high glucose levels. Who this helps: This benefits patients with relapsed iNHL who have previously responded to rituximab, offering them a potential new treatment option.

Plain English
This study looked at how physical activity changed among adults in Qom, Iran, before and during the COVID-19 pandemic. Researchers found that physical activity levels dropped significantly, with 78% of people not meeting the recommended guidelines for exercise during the pandemic. This decline in activity is important because it can lead to health issues, highlighting the need for strategies to encourage exercise during such restrictive times. Who this helps: This benefits patients and health officials who are looking to improve public health.

Plain English
This study examined how effective magnetic resonance imaging (MRI) is for diagnosing knee injuries by comparing its results to those from knee surgery in 98 patients. The findings showed that MRI was very good at detecting injuries to the inner cartilage of the knee (medial meniscus), and it was particularly reliable in ruling out problems with the ligament in the back of the knee (posterior cruciate ligament). This is important because a normal MRI can help avoid unnecessary surgeries for patients. Who this helps: Patients with knee injuries.

Plain English
This study examined the use of platelet-rich plasma (PRP) injections guided by ultrasound to treat chronic shoulder pain caused by rotator cuff tendon issues. Researchers treated 17 patients with a specific type of tendon tear and found that their shoulder function improved significantly, with scores rising from an average of 37.05 to 61.76 after three months. This matters because it shows that a single PRP injection can help relieve pain and enhance movement for patients who haven't benefited from other treatments. Who this helps: This benefits patients suffering from chronic shoulder pain related to rotator cuff tendon issues.

Plain English
This study looked at a surgical method called the modified Matti-Russe technique to treat scaphoid nonunion fractures, which are challenging injuries in the wrist. Out of 30 patients treated, 86.7% had healed fractures by six months, and the average wrist function score was 75 out of 100. This matters because it shows this surgical technique can effectively help many young patients recover wrist function after a difficult injury. Who this helps: Patients with scaphoid nonunion fractures.

Plain English
This study looked at a surgical method called 1,2 ICSRA to treat patients with scaphoid bone fractures that had not healed properly and had lost blood supply. Over a period of 24 months, all 16 male participants, aged around 27, were treated, and the results showed that 100% of them healed the fracture by 12 weeks. Their wrist function improved significantly after surgery, going from an average score of about 37 to nearly 84 on a wrist function scale, indicating that this technique is effective for this type of injury. Who this helps: This benefits patients with non-healing wrist fractures, particularly young men.

Plain English
This study focused on adapting and validating the Oxford Hip Score (OHS) questionnaire for Persian-speaking patients in Iran who underwent hip surgery. Researchers tested the questionnaire on 105 patients and found it to be reliable and consistent; the average OHS score was 42.7. This matters because a culturally adapted tool helps accurately assess patients' pain and function, leading to better care and treatment for those with hip issues. Who this helps: This helps patients undergoing hip surgery in Iran.

Plain English
This study looked at how the median nerve in the wrist changes in advanced carpal tunnel syndrome, a condition that affects hand function. Researchers evaluated 80 patients who had serious symptoms and underwent surgery, finding that 10 had a specific point of constriction in their nerves, while 6 had more widespread constriction. Post-surgery results showed a significant improvement: pain levels dropped from an average of 8-9 to 3-4, two-point discrimination improved from 14 mm to 8 mm, and grip strength increased from 10 kg to 21 kg. Who this helps: This benefits patients with advanced carpal tunnel syndrome and their doctors by informing better treatment options to improve outcomes.